1. Home
  2. Lenalidomide
  Subject:

Lenalidomide   New Search

View on DBpedia    View on Wikipedia
Top related subjects:
 Multiple myeloma Thalidomide Dexamethasone Progression-free survival Bortezomib Thrombocytopenia Syndrome Proteasome inhibitor Monoclonal antibody Hematopoietic stem cell Lenalidomide Plasma cell Chemotherapy Blood plasma Lymphoma Protein Phosphorylation Messenger RNA Multivariate analysis Breast cancer Estrogen receptor Neutropenia Proteasome Western blot Anemia Fever Gene Obesity Hypertension Phenotype Ubiquitin Antibody Growth factor Pharmacokinetics Antigen Acute myeloid leukemia Haematopoiesis Graft-versus-host disease Disease Bone marrow
RELATED SUBJECTS:
The publications listed also have these subjects
Multiple myeloma  8 times
Dexamethasone  5 times
Progression-free survival  3 times
Bortezomib  3 times
Thrombocytopenia  2 times
Syndrome  2 times
Monoclonal antibody  2 times
Hematopoietic stem cell  2 times
Chemotherapy  2 times
Tumor necrosis factor alpha  1 time
Thrombosis  1 time
T cell  1 time
Rituximab  1 time
Queensland  1 time
Protein  1 time
Proportional hazards model  1 time
Polyneuropathy  1 time
Pleural effusion  1 time
Plasma cell  1 time
Placebo  1 time
Pharmacokinetics  1 time
Peripheral neuropathy  1 time
Monocyte  1 time
Management system  1 time
Lymphoproliferative disorders  1 time
Karyotype  1 time
Interferon  1 time
Hematopoietic stem cell transplantation  1 time
Growth factor  1 time
Graft-versus-host disease  1 time
European Union  1 time
Estrogen receptor  1 time
Diarrhea  1 time
Cyclophosphamide  1 time
Cutaneous condition  1 time
ClinicalTrials.gov  1 time
Clinical trial  1 time
Chemotaxis  1 time
CD34  1 time
Bone marrow  1 time
Blood plasma  1 time
Birth control  1 time
Australia  1 time
Ascites  1 time
Antibody  1 time
Anemia  1 time
Albumin  1 time
Acute myeloid leukemia  1 time
21 Days  1 time

Publications tagged with this subject: 13

Note: Top 50 publications shown only. Open an item panel to view more info (open all)


1. Lenalidomide: A Review in Newly Diagnosed Multiple Myeloma as Maintenance Therapy After ASCT

2. The Clinical Pharmacology of Elotuzumab

3. The Cost Impact of Lenalidomide for Newly Diagnosed Multiple Myeloma in the EU5

4. Peripheral blood cytogenetics allows treatment monitoring and early identification of treatment failure to lenalidomide in MDS patients: results of the LE-MON-5 trial

5. Using pharmacy management systems for research: survival outcomes for lenalidomide in multiple myeloma in the clinical setting

6. Hematopoietic stem cell transplantation: up-date from ASH 2016

7. Dose and Schedule Selection of the Oral Proteasome Inhibitor Ixazomib in Relapsed/Refractory Multiple Myeloma: Clinical and Model-Based Analyses

8. Immunomodulatory Drugs in Multiple Myeloma: Mechanisms of Action and Clinical Experience

9. Improved survival in Medicare patients with multiple myeloma: findings from a large nationwide and population-based cohort

10. Effectiveness of Risk Evaluation and Mitigation Strategies (REMS) for Lenalidomide and Thalidomide: Patient Comprehension and Knowledge Retention

11. Salvage therapy with lenalidomide containing regimen for relapsed/refractory Castleman disease: a report of three cases

12. Carfilzomib and lenalidomide response related to VEGF and VEGFR2 germline polymorphisms

13. A phase III study of lenalidomide maintenance after debulking therapy in patients with advanced cutaneous T-cell lymphoma - EORTC 21081 (NCT01098656): results and lessons learned for future trial designs


Questions?

Drop us a message.